Let's Build Better Cells Together

Navigate your way from concept to clinic by partnering with MaxCyte^®.

We've spent over 20 years perfecting the art of cell engineering and venturing beyond today's process to innovate tomorrow's solutions. Our ExPERT™ instruments feature best-in-class electroporation technology combining high efficiency and cell viability with seamless scalability, all backed by a global team of technical and regulatory experts providing ongoing support.

We provide the spark of collaboration empowering research into treatments and cures that will transform human health. Chart your best course with MaxCyte.

Electroporation Systems

Achieve efficient delivery that's consistent and scalable.

View all instruments

Technology

Find out how over 20 years of optimization delivers unparalleled performance.

Discover how our technology works

Support

Move confidently with experienced cell engineering specialists at your side.

Understand our technical & regulatory support

Research Applications

Cell Therapy

Discover scalable engineering to enable safe and potent cell therapies.

Cell Based Assays

Produce assay-ready cells faster with scalable electroporation.

Antibody & Protein Production

Accelerate biotherapeutic development with transient expression for gram-scale protein production.

Viral Vector Production

Transfect adherent or suspension cells to produce a variety of viral vectors.

Gene Editing

Navigate the complexities of genome engineering with highly efficient delivery.

Vaccine

Innovate vaccine research with our adaptable platform for production of recombinant proteins, virus-like particles and more.

The equipment is reliable and the customer service is the best I've ever experienced in a biotech company.

Joshua Sasine, Assistant Professor of Medicine Cedars-Sinai Medical Center

The customer service is top notch. The representatives are friendly and knowledgeable. They are generous with their time and it greatly enhances the utility of the machines.

Joshua Sasine, Assistant Professor of Medicine Cedars-Sinai Medical Center

User friendly interface, well established protocols, and supportive MaxCyte team.

Akitsu Hotta, Associate Professor CiRA, Kyoto University

We discussed the optimization of electroporation conditions with MaxCyte researchers...This experience helped us a lot in the development of our T-cell product and we were very impressed with the kind and reliable discussions with the MaxCyte team.

Shigeki Yagyu, Professor Shinshu University

MaxCyte Enabled Successful Transfection of Difficult Primary Human T-Cells "Working with notoriously challenging unstimulated primary human T-cells, we turned to the MaxCyte platform. We achieved acceptable transfection efficiency and cell viability when performing a double transfection of two large plasmids (9kb and 6kb).

Graduate Student - Renowned US Academic Center

Hands-On Expertise from MaxCyte's Research Specialist "MaxCyte pleasantly surprised us by having their research specialist personally conduct the demo, including cell culture. This approach allowed us to absorb information and ask questions without the pressure of learning everything in a single day. In contrast, other companies sent non-scientist representatives who merely instructed us."

Graduate Student - Renowned US Academic Center

MaxCyte paired us with a research specialist who had a PhD and years of experience who was actually able to support us scientifically.

Graduate Student - Renowned US Academic Center

As we are new to the technology, we wanted to partner with a company that offered great products and great customer service. Our sales & FAS team have been terrific. They are willing to go the extra mile to help their customers with any questions or problems they may be having. They are generous with their time and patiently go through the training process with our team.

Joe Huey, Development Technologist

Explore the research we've supported

See how MaxCyte technology is advancing our partners' biomedical innovations

Application Note

Triple-Engineered NYCE cells as T Cell Therapy for Refractory Cancers

Poster

Clinical Scale Delivery of nS/MARt Vectors for CAR T Cell Engineering

Application Note

Highly Efficient CAR T Cell Engineering, with CRISPR and Single-Stranded Cas9 Target Sequences.

We're here throughout your journey

Because bringing a new therapeutic to market is a long and complex endeavor, we offer our expertise to support your innovations and chart a more direct course to success.

The benefits of our collaborative approach can be seen in over 35 clinical trials. Our technology has enabled studies by leaders in pharmaceutical and biotechnology research developing treatments for a variety of indications including cancer, heart disease, central nervous system disorders and rare genetic diseases.

Learn More About Us